Treatment options of AIDS-related lymphoma (Q35183751)

7 August 2017

1 reference

title

Treatment options of AIDS-related lymphoma (English)

1 reference

primary effusion lymphoma

7 August 2017

main subject

1 reference

2

Jürgen K Rockstroh

1 reference

7 August 2017

author name string

Ingo G H Schmidt-Wolf

1

1 reference

7 August 2017

Uwe Schlegel

3

1 reference

7 August 2017

Hendrik Pels

4

1 reference

7 August 2017

Ulrich Mey

5

1 reference

7 August 2017

John Strehl

6

1 reference

7 August 2017

Rudolf Weiss

7

1 reference

7 August 2017

Dieter Huhn

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1331-1343

1 reference

Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Could bone marrow transplantation cure AIDS?: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

21 January 2018

AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.8.1331

10.1517/14656566.4.8.1331

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference